CTI BioPharma Corp. (CTIC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.34-0.01 (-2.76%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close0.35
Bid0.30 x 1000
Ask0.37 x 10000
Day's Range0.34 - 0.37
52wk Range0.25 - 1.75
1y Target EstN/A
Market Cap97.57M
P/E Ratio (ttm)-1.06
Avg Vol (3m)1,301,643
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Associated Press21 days ago

    CTI BioPharma reports 2Q loss

    The Seattle-based company said it had a loss of 7 cents per share. Losses, adjusted for stock option expense, came to 6 cents per share. The biotechnology company posted revenue of $7.4 million in the ...

  • PR Newswire21 days ago

    CTI BioPharma Reports Second Quarter 2016 Financial Results

    SEATTLE, Aug. 4, 2016 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ and MTA:CTIC) today reported financial results for the second quarter ended June 30, 2016. "The interest from oncologists generated ...

  • Capital Cubelast month

    ETF’s with exposure to CTI BioPharma Corp. : July 20, 2016

    Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to CTI BioPharma Corp.Here are 5 ETF’s with the largest exposure to CTIC-US. Comparing the performance and risk of CTI BioPharma Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us […] (Read more...) The post ETF’s with exposure to CTI BioPharma Corp. : July 20, 2016 appeared first on CapitalCube.